São Paulo City launches filming attraction program - Agência de Notícias Brasil-Árabe anba.com.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from anba.com.br Daily Mail and Mail on Sunday newspapers.
Study confirms high doses of vitamin D have no effect on COVID-19
Written by Robby Berman on May 4, 2021 Fact checked by Catherine Carver, MPH
The role of vitamin D in COVID-19 has been of much discussion. Gennaro Leonardi/EyeEm/Getty Images
Researchers have wondered whether vitamin D may help people avoid SARS-CoV-2 infections and mitigate the effects of COVID-19.
A randomized, double-blind, placebo-controlled clinical trial seeks to test vitamin D’s usefulness in combatting the disease.
The study finds high doses of vitamin D have no effect on key COVID-19 outcomes in particularly ill hospitalized patients.
Further research is needed to investigate whether a deficiency of vitamin D is associated with more severe cases of COVID-19.
High dose of vitamin D does not have a beneficial effect on moderate or severe COVID-19 patients
Can a high dose of vitamin D administered on admission to hospital improve the condition of patients with moderate or severe COVID-19? The answer is no, according to a Brazilian study published in the
Journal of the American Medical Association (JAMA).
The article reports a randomized, double-blind, placebo-controlled clinical trial, the kind of study considered the gold standard to evaluate drug efficacy. It was conducted with FAPESP s support by researchers at the University of São Paulo s Medical School (FM-USP), who recruited 240 patients treated at Hospital das Clínicas (HC), the hospital complex run by FM-USP, and the Ibirapuera field hospital in São Paulo City in June-August 2020.
The U.S. new cases 7-day rolling average are 12.4 % LOWER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 4.3 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 65,471
U.S. Coronavirus deaths are at 901
U.S. Coronavirus immunizations have been administered to 64.6 % of the population
The 7-day rolling average rate of growth of the pandemic shows new cases improved and deaths worsened
CDC advisers recommend resuming use of Johnson & Johnson coronavirus vaccine
New Study Shows Long Haul COVID-19 Can Kill Patients Months After Infection
E-Mail
IMAGE: The supplementation of vitamin D3 did not reduce length of stay or affect the proportion requiring intensive care. view more
Credit: Rosa Pereira
By Karina Toledo | Agência FAPESP – Can a high dose of vitamin D administered on admission to hospital improve the condition of patients with moderate or severe COVID-19? The answer is no, according to a Brazilian study
Journal of the American Medical Association (JAMA).
The article reports a randomized, double-blind, placebo-controlled clinical trial, the kind of study considered the gold standard to evaluate drug efficacy. It was conducted with
FAPESP’s support by researchers at the University of São Paulo’s Medical School (FM-USP), who recruited 240 patients treated at Hospital das Clínicas (HC), the hospital complex run by FM-USP, and the Ibirapuera field hospital in São Paulo City in June-August 2020.